Effect of exogenous cholecystokinin on islet blood flow in anesthetized rats

Regulatory Peptides

Volumn 116, Issue 1-3, 2003, Pages 87-93

  Iwase, Masanori ^a   Uchizono, Yuji ^a   Nakamura, Udai ^a   Nohara, Sakae ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cholecystokinin receptor; NG monomethyl L arginine; Nitric oxide; Otsuka Long Evans Tokushima Fatty rats; Pancreatic blood flow; Vagus nerve

Indexed keywords

CHOLECYSTOKININ; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; ENDOCRINE CELL; EXOCRINE CELL; MALE; MICROPHOTOGRAPHY; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; VAGOTOMY;

EID: 0242266547     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2003.07.002     Document Type: Article

References (35)

1. Inoue K., Kawano T., Kogire M., Takaori K., Suzuki T., Tobe T. Microcirculatory response of the pancreas to feeding, sham feeding, and truncal vagotomy in conscious dogs. Pancreas. 8:1993;28-33.
2. Nakajima M., Naruse S., Kitagawa M., Ishiguro H., Jin C., Ito O.et al. Role of cholecystokinin in the intestinal phase of pancreatic circulation in dogs. Am. J. Physiol. 280:2001;G614-G620.
3. Jansson L. The regulation of pancreatic islet blood flow. Diabetes Metab. Rev. 10:1994;407-416.
4. Aune S., Semb L.S. The effect of secretin and pancreozymin on pancreatic blood flow in the conscious and anesthetized dog. Acta Physiol. Scand. 76:1969;406-414.
5. Frogge J.D., Hermreck A.S., Thal A.P. Metabolic and hemodynamic effects of secretin and pancreozymin on the pancreas. Surgery. 68:1970;498-502.
6. Hickson J.C. The secretory and vascular response to nervous and hormonal stimulation in the pancreas of the pig. J. Physiol. (Lond.). 206:1970;299-322.
7. Goodhead B., Himal H.S., Zanbilowicz J. Relationship between pancreatic secretion and pancreatic blood flow. Gut. 11:1970;62-68.
8. Harper S.L., Pitts V.H., Granger D.N., Kvietys P.R. Pancreatic tissue oxygenation during secretory stimulation. Am. J. Physiol. 250:1986;G316-G322.
9. Doi R., Hosotani R., Inoue K., Kogire M., Sumi S., Fujii N.et al. Effect of synthetic human cholecystokinin-33 on pancreatic blood flow in dogs. Pancreas. 5:1990;615-620.
10. Karlsson S., Ahren B. Cholecystokinin and the regulation of insulin secretion. Scand. J. Gastroenterol. 27:1992;161-165.
11. Carlsson P.O., Jansson L. Whole pancreatic blood flow and islet blood flow after pancreatico-biliary diversion in rats. Med. Sci. Res. 24:1996;11-12.
12. Iwase M., Tashiro K., Uchizono Y., Goto D., Yoshinari M. Pancreatic islet blood flow in conscious rats during hyperglycemia and hypoglycemia. Am. J. Physiol. 280:2001;R1601-R1605.
13. Plusczyk T., Bauer M., Marzi I., Harbauer G., Feifel G. Comparative effects of secretin (SEC) and cholecystokinin-octapeptide (CCK-8) on pancreatic microcirculation. Dig. Dis. Sci. 40:1995;1199-1206.
14. Tachibana I., Watanabe N., Shirohara H., Akiyama T., Nanano S., Otsuki M. Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats. Int. J. Pancreatol. 17:1995;147-154.
15. Iwase M., Sandler S., Carlsson P.O., Hellerstrom C., Jansson L. The pancreatic islets in spontaneously hypertensive rats: islet blood flow and insulin production. Eur. J. Endocrinol. 144:2001;169-178.
16. Iwase M., Uchizono Y., Tashiro K., Goto D., Iida M. Islet hyperperfusion during prediabetic phase in OLETF rats, a model of type 2 diabetes. Diabetes. 51:2002;2530-2535.
17. Svensson A.M., Ostenson C.G., Efendic S., Jansson L. Effect of GLP-1(7-36) amide on pancreatic and intestinal blood flow in the spontaneously diabetic GK rat. Diabetologia. 37(Suppl. 1):1994;A72.
18. Svensson A.M., Efendic S., Ostenson C.G., Jansson L. Gastric inhibitory polypeptide and splanchnic blood perfusion. Augmentation of the islet blood flow increase in hyperglycemic rats. Peptides. 18:1997;1055-1059.
19. Ebert R., Creutzfeldt W. Gastrointestinal peptides and insulin secretion. Diabetes Metab. Rev. 3:1987;1-26.
20. Chey W.Y. Regulation of pancreatic exocrine secretion. Int. J. Pancreatol. 9:1991;7-20.
21. Carlsson P.O., Jansson L. Secretin and pancreatic islet blood flow in anesthetized rats: increased insulin secretion with no augmentation of blood perfusion. World J. Surg. 25:2001;835-839.
22. Homma T., Malik K.U. Effect of secretin and caerulein in canine pancreas. Relation to prostaglandins. Am. J. Physiol. 244:1983;G660-G667.
23. Janssen P.J., Gardiner S.M., Compton A.M., Bennett T. Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious Long Evans rats. Br. J. Pharmacol. 102:1991;123-134.
24. Patel A.G., Toyama M.T., Nguyen T.N., Cohen G.A., Ignarro L.J., Reber H.A.et al. Role of nitric oxide in the relationship of pancreatic blood flow and exocrine secretion in cats. Gastroenterology. 108:1995;1215-1220.
25. Carlsson P.-O., Jansson L., Palm F. Unaltered oxygen tension in rat pancreatic islets despite dissociation of insulin release and islet blood flow. Acta Physiol. Scand. 176:2002;275-281.
26. Karlsson S., Sundler F., Ahren B. CCK receptor subtype in insulin-producing cells: a combined functional and in situ hybridization study in rat islets and a rat insulinoma cell line. Regul. Pept. 78:1998;95-103.
27. Zawalich W.S., Diaz V.A., Zawalich K.C. Stimulatory effects of cholecystokinin on isolated perfused islets inhibited by potent and specific antagonist L 364718. Diabetes. 37:1988;1432-1437.
28. Karlsson S., Ahren B. CCKA receptor antagonism inhibits mechanisms underlying CCK-8-stimulated insulin release in isolated rat islets. Eur. J. Pharmacol. 202:1991;253-257.
29. Sakamoto C., Goldfine I.D., Roach E., Williams J.A. Localization of saturable CCK binding sites in rat pancreatic islets by light and electron microscope autoradiography. Diabetes. 34:1985;390-394.
30. Funakoshi A., Miyasaka K., Shinozaki H., Masuda M., Kawanami T., Takata Y.et al. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem. Biophys. Res. Commun. 210:1995;787-796.
31. Tachibana I., Akiyama T., Kanagawa K., Shiohara H., Furumi K., Watanabe N.et al. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats. Am. J. Physiol. 270:1996;G730-G737.
32. Funakoshi A., Miyasaka K., Kanai S., Masuda M., Yasunami Y., Nagai T.et al. Pancreatic endocrine dysfunction in rats not expressing the cholecystokinin-A receptor. Pancreas. 12:1996;230-236.
33. Larsson L.I., Rehfeld J.F. Peptidergic and adrenergic innervation of pancreatic ganglia. Scand. J. Gastroenterol. 14:1979;433-437.
34. Larsson L.I. Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin/CCK immunoreactive nerves. J. Histochem. Cytochem. 27:1979;1283-1284.
35. Shimizu K., Kato Y., Shiratori K., Ding Y., Song Y., Furlanetto R.et al. Evidence for the existence of CCK-producing cells in rat pancreatic islets. Endocrinology. 139:1998;389-396.